RIP1 mediates the protection of geldanamycin on neuronal injury induced by oxygen‐glucose deprivation combined with zVAD in primary cortical neurons
Open Access
- 11 October 2011
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 120 (1), 70-77
- https://doi.org/10.1111/j.1471-4159.2011.07526.x
Abstract
J. Neurochem. (2012) 120, 70–77. Abstract Caspase-dependent apoptosis is considered one of the most important cell death pathways. When the apoptotic process is blocked, a form of programmed necrosis called necroptosis occurs. Apoptosis and necroptosis may share some regulatory mechanisms. Recent studies indicated that receptor interacting protein 1 (RIP1), an Hsp90-associated kinase, is an important regulatory switch between apoptosis and necroptosis. In this study, we showed that oxygen-glucose deprivation (OGD) combined with a caspase inhibitor zVAD (OGD/zVAD)-induced RIP1 protein expression in a time-dependent manner. We found that geldanamycin (GA), a benzoquinone ansamycin, protected against neuronal injury induced by OGD/zVAD treatment in cultured primary neurons. More importantly, GA decreased RIP1 protein level in a time- and concentration-dependent manner. In this study, we found that GA also decreased the Hsp90 protein level, which caused instability of RIP1 protein, resulting in decreased RIP1 protein level but not RIP1 mRNA level after GA treatment. We concluded that the GA-mediated protection against OGD/zVAD-induced neuronal injury was associated with enhanced RIP1 protein instability by decreasing Hsp90 protein level. GA and its derivatives may be promising for the prevention of neuronal injury during ischemic injury.Keywords
This publication has 29 references indexed in Scilit:
- A Signaling Cascade of Nuclear Calcium-CREB-ATF3 Activated by Synaptic NMDA Receptors Defines a Gene Repression Module That Protects against Extrasynaptic NMDA Receptor-Induced Neuronal Cell Death and Ischemic Brain DamageJournal of Neuroscience, 2011
- Necrostatin Decreases Oxidative Damage, Inflammation, and Injury after Neonatal HIJournal of Cerebral Blood Flow & Metabolism, 2010
- Heat shock protein 90 in neurodegenerative diseasesMolecular Neurodegeneration, 2010
- Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death PathwayCell, 2008
- c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB ActivationOnline Journal of Public Health Informatics, 2008
- TNF-α Induces Two Distinct Caspase-8 Activation PathwaysCell, 2008
- A biochemical rationale for the anticancer effects of Hsp90 inhibitors: Slow, tight binding inhibition by geldanamycin and its analoguesProceedings of the National Academy of Sciences of the United States of America, 2006
- Geldanamycin treatment reduces delayed CA1 damage in mouse hippocampal organotypic cultures subjected to oxygen glucose deprivationNeuroscience Letters, 2005
- Modulation of prion protein structural integrity by geldanamycinGlycobiology, 2003
- An introduction to the changes in gene expression that occur after cerebral ischaemiaBritish Journal of Neurosurgery, 2000